These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

295 related articles for article (PubMed ID: 29928883)

  • 1. Suppression of cleavage factor Im 25 promotes the proliferation of lung cancer cells through alternative polyadenylation.
    Huang J; Weng T; Ko J; Chen NY; Xiang Y; Volcik K; Han L; Blackburn MR; Lu X
    Biochem Biophys Res Commun; 2018 Sep; 503(2):856-862. PubMed ID: 29928883
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Cancer-Specific Ubiquitin Ligase Drives mRNA Alternative Polyadenylation by Ubiquitinating the mRNA 3' End Processing Complex.
    Yang SW; Li L; Connelly JP; Porter SN; Kodali K; Gan H; Park JM; Tacer KF; Tillman H; Peng J; Pruett-Miller SM; Li W; Potts PR
    Mol Cell; 2020 Mar; 77(6):1206-1221.e7. PubMed ID: 31980388
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Downregulation of CFIm25 amplifies dermal fibrosis through alternative polyadenylation.
    Weng T; Huang J; Wagner EJ; Ko J; Wu M; Wareing NE; Xiang Y; Chen NY; Ji P; Molina JG; Volcik KA; Han L; Mayes MD; Blackburn MR; Assassi S
    J Exp Med; 2020 Feb; 217(2):. PubMed ID: 31757866
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CFIm25 links alternative polyadenylation to glioblastoma tumour suppression.
    Masamha CP; Xia Z; Yang J; Albrecht TR; Li M; Shyu AB; Li W; Wagner EJ
    Nature; 2014 Jun; 510(7505):412-6. PubMed ID: 24814343
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Involved microRNAs in alternative polyadenylation intervene in breast cancer via regulation of cleavage factor "CFIm25".
    Tamaddon M; Shokri G; Hosseini Rad SMA; Rad I; Emami Razavi À; Kouhkan F
    Sci Rep; 2020 Jul; 10(1):11608. PubMed ID: 32665581
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CFIm25 and alternative polyadenylation: Conflicting roles in cancer.
    Jafari Najaf Abadi MH; Shafabakhsh R; Asemi Z; Mirzaei HR; Sahebnasagh R; Mirzaei H; Hamblin MR
    Cancer Lett; 2019 Sep; 459():112-121. PubMed ID: 31181319
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genome-wide profiling reveals alternative polyadenylation of mRNA in human non-small cell lung cancer.
    Zhang S; Zhang X; Lei W; Liang J; Xu Y; Liu H; Ma S
    J Transl Med; 2019 Aug; 17(1):257. PubMed ID: 31391087
    [TBL] [Abstract][Full Text] [Related]  

  • 8. NUDT21 negatively regulates PSMB2 and CXXC5 by alternative polyadenylation and contributes to hepatocellular carcinoma suppression.
    Tan S; Li H; Zhang W; Shao Y; Liu Y; Guan H; Wu J; Kang Y; Zhao J; Yu Q; Gu Y; Ding K; Zhang M; Qian W; Zhu Y; Cai H; Chen C; Lobie PE; Zhao X; Sun J; Zhu T
    Oncogene; 2018 Aug; 37(35):4887-4900. PubMed ID: 29780166
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nudt21 regulates the alternative polyadenylation of Pak1 and is predictive in the prognosis of glioblastoma patients.
    Chu Y; Elrod N; Wang C; Li L; Chen T; Routh A; Xia Z; Li W; Wagner EJ; Ji P
    Oncogene; 2019 May; 38(21):4154-4168. PubMed ID: 30705404
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CPSF3 regulates alternative polyadenylation of CNIH2 to promote esophageal squamous cell carcinoma progression.
    Zhang Y; Liu D; Guo D; Lin W; Lu W; Hu L; Chen S; Chen C
    Cancer Lett; 2024 Jul; 593():216925. PubMed ID: 38718887
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SRSF3 and SRSF7 modulate 3'UTR length through suppression or activation of proximal polyadenylation sites and regulation of CFIm levels.
    Schwich OD; Blümel N; Keller M; Wegener M; Setty ST; Brunstein ME; Poser I; Mozos IRL; Suess B; Münch C; McNicoll F; Zarnack K; Müller-McNicoll M
    Genome Biol; 2021 Mar; 22(1):82. PubMed ID: 33706811
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The emerging roles of CFIm25 (NUDT21/CPSF5) in human biology and disease.
    Masamha CP
    Wiley Interdiscip Rev RNA; 2023; 14(3):e1757. PubMed ID: 35965101
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cleavage factor Im (CFIm) as a regulator of alternative polyadenylation.
    Hardy JG; Norbury CJ
    Biochem Soc Trans; 2016 Aug; 44(4):1051-7. PubMed ID: 27528751
    [TBL] [Abstract][Full Text] [Related]  

  • 14. LINC00921 reduces lung cancer radiosensitivity by destabilizing NUDT21 and driving aberrant MED23 alternative polyadenylation.
    Zhang N; Liu X; Huang L; Zeng J; Ma C; Han L; Li W; Yu J; Yang M
    Cell Rep; 2023 Dec; 42(12):113479. PubMed ID: 37999979
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The microRNA target site landscape is a novel molecular feature associating alternative polyadenylation with immune evasion activity in breast cancer.
    Kim S; Bai Y; Fan Z; Diergaarde B; Tseng GC; Park HJ
    Brief Bioinform; 2021 May; 22(3):. PubMed ID: 32844230
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Upregulation of cleavage and polyadenylation specific factor 4 in lung adenocarcinoma and its critical role for cancer cell survival and proliferation.
    Chen W; Guo W; Li M; Shi D; Tian Y; Li Z; Wang J; Fu L; Xiao X; Liu QQ; Wang S; Huang W; Deng W
    PLoS One; 2013; 8(12):e82728. PubMed ID: 24358221
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cleavage and polyadenylation specific factor 4 targets NF-κB/cyclooxygenase-2 signaling to promote lung cancer growth and progression.
    Yi C; Wang Y; Zhang C; Xuan Y; Zhao S; Liu T; Li W; Liao Y; Feng X; Hao J; Gao Y; Yu W; Chen Y; Zhang C; Guo W; Tang B; Deng W
    Cancer Lett; 2016 Oct; 381(1):1-13. PubMed ID: 27450326
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Implications of polyadenylation in health and disease.
    Curinha A; Oliveira Braz S; Pereira-Castro I; Cruz A; Moreira A
    Nucleus; 2014; 5(6):508-19. PubMed ID: 25484187
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cleavage factor 25 deregulation contributes to pulmonary fibrosis through alternative polyadenylation.
    Weng T; Ko J; Masamha CP; Xia Z; Xiang Y; Chen NY; Molina JG; Collum S; Mertens TC; Luo F; Philip K; Davies J; Huang J; Wilson C; Thandavarayan RA; Bruckner BA; Jyothula SS; Volcik KA; Li L; Han L; Li W; Assassi S; Karmouty-Quintana H; Wagner EJ; Blackburn MR
    J Clin Invest; 2019 May; 129(5):1984-1999. PubMed ID: 30830875
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Knock-down of 25 kDa subunit of cleavage factor Im in Hela cells alters alternative polyadenylation within 3'-UTRs.
    Kubo T; Wada T; Yamaguchi Y; Shimizu A; Handa H
    Nucleic Acids Res; 2006; 34(21):6264-71. PubMed ID: 17098938
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.